Citation Impact
Citing Papers
PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8+ T Cells and Facilitates Anti–PD-1 Therapy
2018 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Skin cancer in liver transplant recipients
2000
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
2002
Head and Neck Cancer in Cardiothoracic Transplant Recipients
2000
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
BK virus infection in renal allograft recipients
2003
Increasing the Opportunity of Live Kidney Donation by Matching for Two- and Three-Way Exchanges
2006 StandoutNobel
Transplant Accommodation in Highly Sensitized Patients: A Potential Role for Bcl-xL and Alloantibody
2001
Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene
2006
THE EPIDEMIOLOGY OF AIDS-RELATED NEOPLASMS
1996
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Determinants of Poor Graft Outcome in Patients with Antibody-Mediated Acute Rejection
2007
Tolerogenic Functions of Human Leukocyte Antigen G: From Pregnancy to Organ and Cell Transplantation
2007
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Desensitization and Subsequent Kidney Transplantation of Patients Using Intravenous Immunoglobulins (IVIg)
2002
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease
2007
Viral Infection in the Renal Transplant Recipient
2005
PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS
2000
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials1
2004
Immunoadsorption of factor VIII inhibitors
2004
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
New Immunosuppressive Agents for Maintenance Therapy in Organ Transplantation
1997
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
2011 StandoutNobel
High incidence of secondary brain tumours after radiotherapy and antimetabolites
1999
Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations
2005 Standout
Skin Cancers after Organ Transplantation
2003 Standout
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
1999
The Evidence for the Use of Recombinant Human Activated Factor VII in the Treatment of Bleeding Patients With Quantitative and Qualitative Platelet Disorders
2007
Testing for Polyomavirus Type BK DNA in Plasma to Identify Renal-Allograft Recipients with Viral Nephropathy
2000
Molecular genotyping of BK and JC viruses in human polyomavirus[ndash ]associated interstitial nephritis after renal transplantation
2001
Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma
2007
Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells
2013
De novo tumors after liver transplantation: A single-institution experience
2002
Polyomavirus in kidney and kidney‐‐pancreas transplant recipients
2003
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Gemcitabine-associated hemolytic-uremic syndrome
2002
Strategies for immunotherapy of cancer
2000
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
BK-virus nephropathy in renal transplants—tubular necrosis, MHC-class II expression and rejection in a puzzling game
2000
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
2008
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension
2011
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Costimulatory blockade with belatacept in clinical and experimental transplantation – a review
2009
Quantitation of BK Virus Load in Serum for the Diagnosis of BK Virus–Associated Nephropathy in Renal Transplant Recipients
2001
Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience
2015
Apheresis for Renal Disease
2001
Novel human polyomaviruses—Re‐emergence of a well known virus family as possible human carcinogens
2008 StandoutNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Kaposi's Sarcoma
2000 Standout
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab
2010
Is therapeutic plasma exchange indicated for patients with gemcitabine‐induced hemolytic uremic syndrome?
2009
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Long-term survival in renal transplant recipients with graft function
2000 Standout
Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin
2005
Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent
2009 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Desensitization in kidney transplantation: review and future perspectives
2014
Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells
2007 Standout
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
2017 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells
2006
Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis
2004
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
The cost-effectiveness of induction immunosuppression in kidney transplantation
2009
UV Radiation and the Skin
2013 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
CTLA-4 and PD-1 Pathways
2015 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of F Kriaa being referenced
Single-Center experience with cyclosporine therapy for kidney transplantation: analysis of a Twenty-Year period in 1200 patients
2004
Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis
1995
Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine
1999
Late graft failure and death in renal transplant recipients: Analysis in a single-center population of 1500 patients
1997
Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti‐glycoprotein IIb–IIIa antibodies
2002
Incidence of Renal and Liver Rejection and Patient Survival Rate Following Combined Liver and Kidney Transplantation
2003
Immunoadsorption of anti-HLA antibodies for highly sensitized patients awaiting renal transplantation
1992
Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia
2001
Malignancy after renal transplantation: Analysis of incidence and risk factors in 1700 patients followed during a 25-Year period
1997
Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28–CD80/86 blockade
2007
Post-transplantation polyomavirus infections.
1999
Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: analysis of a 20-year period in 1600 patients.
1995
Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
1993
Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis
2013
How to deal with the hyperimmunized potential recipients.
1992